The Challenges, Opportunities and Performance of the Indian Pharmaceutical Industry Post-TRIPS

  • Dhar B
  • Joseph R
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

India’s generic pharmaceutical producers face numerous challenges after the country’s patent law was amended to make it compatible with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Two amendments were significant:...

Cite

CITATION STYLE

APA

Dhar, B., & Joseph, R. K. (2019). The Challenges, Opportunities and Performance of the Indian Pharmaceutical Industry Post-TRIPS (pp. 299–323). https://doi.org/10.1007/978-981-13-8102-7_13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free